Inquis Medical
Inquis Medical raises $40M Series B at $200M valuation
Quick Facts
Inquis Medical: Series B Funding Round
Inquis Medical has successfully raised $40M in Series B funding, reaching a valuation of $200M.
Company Overview
Medical technology company specializing in thrombectomy systems
Funding Details
The Series B round was led by Marshall Wace, with participation from Cormorant Asset Management.
Company Information
- Headquarters: Menlo Park, CA
- Founded: 2018
- Employees: 70+
- Category: HealthTech
Investment
Inquis Medical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Marshall Wace: Verified investor in Series B
- Cormorant Asset Management: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Duos raises $130M Growth Equity at $600M valuation
Duos raises $130M in Growth Equity at $600M valuation. Digital health platform for Medicare-focused patient care...